The Institute of Biomedical Technology (IBT) at the University of Tampere is dedicated to excel in basic and translational research and education in the field of biomedicine.
Its research activities cover diverse areas, including cancer, immunology, cellular biology, bioinformatics, biotechnology and stem cell based regenerative medicine with a common aim of developing personalized medicine via new diagnostic and treatment methods. IBT also houses FinMIT, the Academy of Finland Centre of Excellence in research on mitochondrial genetics, disease and ageing.
IBT is part of BioMediTech, a joint institute of the University of Tampere (UTA) and Tampere University of Technology (TUT). The collaboration between the universities has enabled a unique research and educational environment. In the autumn 2012 UTA and TUT launched a joint education with the objective to educate top-level experts in life sciences and medical technology.
Welcome to the next IBT Seminar on 27.5. at 14.00 in FM1, 5th floor lecture room.
The speaker is Thora Karadottir, University of Cambridge and the title of her talk is: "Neurons calling: neuronal activity regulates CNS stem cell's (OPCs) fate"
Coffee and snacks before the seminar! Welcome!
Mondays in Finn-Medi 5 Auditorium
1-8.6.2013, Hotel Tallukka
More information: http://www.biomeditech.fi/summerschool2013/
Traditional minisymposium will be organized on 6th June.
Time: 24.5.2013 at 12
Place: University of Tampere, Finn-Medi 5 auditorium, Biokatu 12, Tampere.
Opponent professor Steven A. Wasserman (University of California, USA).
Custos professor Mika Rämet.
A postdoctoral researcher position is available in the PELICAN- Personalized Cancer Medicine project led by FiDiPro-Prof. G. Steven Bova and Prof. Tapio Visakorpi at the Institute of Biomedical Technology, University of Tampere.